Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 6 de 6
Filter
Add more filters










Database
Language
Publication year range
1.
Front Immunol ; 13: 742571, 2022.
Article in English | MEDLINE | ID: mdl-35300331

ABSTRACT

Group 3 helper Innate Lymphoid Cells (ILC3s) are cytokine-producing lymphocytes that respond to stress signals released during disturbed tissue homeostasis and infection. Upon activation, ILC3s secrete IL-22 and IL-17, and orchestrate immune responses against extracellular pathogens. Their role in cancer remains poorly explored. To determine their anti-cancer effector potential, we co-cultured cytokine-activated human ILC3s with cancer cells of different origins. ILC3s were able to directly respond to tumor cells, resulting in enhanced IFN-γ production. Upon tumor cell encounter, ILC3s maintained expression of the transcription factor RORγt, indicating that ILC3s preserved their identity. ILC3s were able to directly kill both hepatocellular carcinoma and melanoma tumor cells expressing cell-death receptor TRAILR2, through the activation of Caspase-8 in target cells. Moreover, liver-derived cytokine-activated ILC3s also expressed TRAIL and were able to eliminate hepatoblastoma cells. Together, our data reveal that ILC3s can participate in anti-tumor immune response through direct recognition of tumor cells resulting in IFN-γ release and TRAIL-dependent cytotoxicity. Thus, ILC3s might be ancillary players of anti-tumor immunity in tissues, acting as primary responders against transformed or metastasizing cells, which might be further exploited for therapies against cancer.


Subject(s)
Lymphocytes , Neoplasms , Cytokines , Gene Expression Regulation , Humans , Immunity, Innate , Interferon-gamma , TNF-Related Apoptosis-Inducing Ligand
2.
Cell Mol Immunol ; 17(4): 347-355, 2020 04.
Article in English | MEDLINE | ID: mdl-31471588

ABSTRACT

Natural killer (NK) cells participate in early immune defenses against pathogens and tumors and play a major role as immune effector and regulatory cells. The NK cell-mediated elimination of an infected or cancerous cell is a highly regulated process that requires the formation of a cell contact, the establishment of an immunological synapse and the polarization and release of lytic granules. Additionally, the detachment of NK cells from target cells is important for NK cells to bind and kill other cells in a process called serial killing. However, very little is known about this detachment process. Here, we show that NK detachment is directly connected to the successful killing of a target cell. The inhibition of killing due to reduced NK cell cytotoxicity or increased target cell resistance results in defective detachment and prolonged contact times. This effect leads to sustained Ca2+ flux in NK cells and the hypersecretion of proinflammatory cytokines. Linking defective cytotoxicity with enhanced cytokine secretion via reduced detachment may explain inflammatory pathologies in several diseases.


Subject(s)
Cytokines/biosynthesis , Cytotoxicity, Immunologic , Killer Cells, Natural/immunology , Calcium/metabolism , Cell Adhesion Molecules/metabolism , Cell Death , Gene Deletion , Humans , K562 Cells , Ligands , Lysosomal-Associated Membrane Protein 1/metabolism , Macrolides/pharmacology , Perforin/metabolism , Receptors, Natural Killer Cell/metabolism , Serpins/metabolism
3.
J Exp Med ; 216(9): 2113-2127, 2019 09 02.
Article in English | MEDLINE | ID: mdl-31270246

ABSTRACT

NK cells eliminate virus-infected and tumor cells by releasing cytotoxic granules containing granzyme B (GrzB) or by engaging death receptors that initiate caspase cascades. The orchestrated interplay between both cell death pathways remains poorly defined. Here we simultaneously measure the activities of GrzB and caspase-8 in tumor cells upon contact with human NK cells. We observed that NK cells switch from inducing a fast GrzB-mediated cell death in their first killing events to a slow death receptor-mediated killing during subsequent tumor cell encounters. Target cell contact reduced intracellular GrzB and perforin and increased surface-CD95L in NK cells over time, showing how the switch in cytotoxicity pathways is controlled. Without perforin, NK cells were unable to perform GrzB-mediated serial killing and only killed once via death receptors. In contrast, the absence of CD95 on tumor targets did not impair GrzB-mediated serial killing. This demonstrates that GrzB and death receptor-mediated cytotoxicity are differentially regulated during NK cell serial killing.


Subject(s)
Cytotoxicity, Immunologic , Granzymes/metabolism , Killer Cells, Natural/immunology , Receptors, Death Domain/metabolism , Caspase 8/metabolism , HeLa Cells , Humans , Kinetics , Perforin/metabolism , fas Receptor/metabolism
4.
J Leukoc Biol ; 105(6): 1319-1329, 2019 06.
Article in English | MEDLINE | ID: mdl-31107565

ABSTRACT

Cellular cytotoxicity, the ability to kill other cells, is an important effector mechanism of the immune system to combat viral infections and cancer. Cytotoxic T cells and natural killer (NK) cells are the major mediators of this activity. Here, we summarize the cytotoxic mechanisms of NK cells. NK cells can kill virally infected of transformed cells via the directed release of lytic granules or by inducing death receptor-mediated apoptosis via the expression of Fas ligand or TRAIL. The biogenesis of perforin and granzymes, the major components of lytic granules, is a highly regulated process to prevent damage during the synthesis of these cytotoxic molecules. Additionally, NK cells have developed several strategies to protect themselves from the cytotoxic activity of granular content upon degranulation. While granule-mediated apoptosis is a fast process, death receptor-mediated cytotoxicity requires more time. Current data suggest that these 2 cytotoxic mechanisms are regulated during the serial killing activity of NK cells. As many modern approaches of cancer immunotherapy rely on cellular cytotoxicity for their effectiveness, unraveling these pathways will be important to further progress these therapeutic strategies.


Subject(s)
Immunity, Cellular , Killer Cells, Natural/immunology , Neoplasms/immunology , Virus Diseases/immunology , Animals , Fas Ligand Protein/immunology , Gene Expression Regulation, Neoplastic/immunology , Humans , Killer Cells, Natural/pathology , Neoplasm Proteins/immunology , Neoplasms/pathology , Virus Diseases/pathology
5.
Front Immunol ; 9: 1840, 2018.
Article in English | MEDLINE | ID: mdl-30135688

ABSTRACT

Natural killer (NK) cells eliminate infected and tumorigenic cells through delivery of granzymes via perforin pores or by activation of caspases via death receptors. In order to understand how NK cells combine different cell death mechanisms, it is important to quantify target cell responses on a single cell level. However, currently existing reporters do not allow the measurement of several protease activities inside the same cell. Here, we present a strategy for the comparison of two different proteases at a time inside individual target cells upon engagement by NK cells. We developed single-fluorescent protein reporters containing the RIEAD or the VGPD cleavage site for the measurement of granzyme B activity. We show that these two granzyme B reporters can be applied in combination with caspase-8 or caspase-3 reporters. While we did not find that caspase-8 was activated by granzyme B, our method revealed that caspase-3 activity follows granzyme B activity with a delay of about 6 min. Finally, we illustrate the comparison of several different reporters for granzyme A, M, K, and H. The approach presented here is a valuable means for the investigation of the temporal evolution of cell death mediated by cytotoxic lymphocytes.


Subject(s)
Caspases/metabolism , Gene Expression , Genes, Reporter , Granzymes/metabolism , Killer Cells, Natural/metabolism , Apoptosis , Cell Death , Humans , Killer Cells, Natural/immunology , Proteolysis , Single-Cell Analysis
6.
BMC Cancer ; 15: 790, 2015 Oct 24.
Article in English | MEDLINE | ID: mdl-26497197

ABSTRACT

BACKGROUND: Tumor-associated macrophages (TAMs) promote tumor progression and have an effect on survival in human cancer. However, little is known regarding their influence on tumor progression and prognosis in human hilar cholangiocarcinoma. METHODS: We analyzed surgically resected tumor specimens of hilar cholangiocarcinoma (n = 47) for distribution and localization of TAMs, as defined by expression of CD68. Abundance of TAMs was correlated with clinicopathologic characteristics, tumor recurrence and patients' survival. Statistical analysis was performed using SPSS software. RESULTS: Patients with high density of TAMs in tumor invasive front (TIF) showed significantly higher local and overall tumor recurrence (both ρ < 0.05). Furthermore, high density of TAMs was associated with decreased overall (one-year 83.6% vs. 75.1%; three-year 61.3% vs. 42.4%; both ρ < 0.05) and recurrence-free survival (one-year 93.9% vs. 57.4%; three-year 59.8% vs. 26.2%; both ρ < 0.05). TAMs in TIF and tumor recurrence, were confirmed as the only independent prognostic variables in the multivariate survival analysis (all ρ < 0.05). CONCLUSIONS: Overall survival and recurrence free survival of patients with hilar cholangiocarcinoma significantly improved in patients with low levels of TAMs in the area of TIF, when compared to those with a high density of TAMs. These observations suggest their utilization as valuable prognostic markers in routine histopathologic evaluation, and might indicate future therapeutic approaches by targeting TAMs.


Subject(s)
Antigens, CD/biosynthesis , Antigens, Differentiation, Myelomonocytic/biosynthesis , Bile Duct Neoplasms/diagnosis , Bile Duct Neoplasms/metabolism , Klatskin Tumor/diagnosis , Klatskin Tumor/metabolism , Macrophages/metabolism , Aged , Bile Duct Neoplasms/pathology , Female , Follow-Up Studies , Humans , Klatskin Tumor/mortality , Macrophages/pathology , Male , Middle Aged , Neoplasm Invasiveness/pathology , Prognosis , Survival Rate/trends
SELECTION OF CITATIONS
SEARCH DETAIL
...